Media

Support Of Industry Underscores Pro-Business Commitment
2014 Livestock Biotech Summit three day programming touched on issues such as engaging consumers, animal welfare, the promise of the technology.

Press Releases

Sep 4 2014
Washington, D.C. (September 4, 2014) – The Biotechnology Industry Organization (BIO) invites biotechnology, pharmaceutical, business development, life...
Sep 4 2014
Washington, D.C. (September 4, 2014) – The Biotechnology Industry Organization (BIO) is pleased to announce the winners of the 2014 BIO Investor Forum...
Sep 3 2014
Washington, D.C. (Sept. 3, 2014) –The Biotechnology Industry Organization (BIO) today congratulates member company POET-DSM on opening Project Liberty...
Sep 3 2014
WASHINGTON, D.C. (September 03, 2014) – South Dakota State University, the South Dakota Biotech Association and select Brookings firms will provide...
Aug 25 2014
Washington, D.C. (August 25, 2014) – The Biotechnology Industry Organization (BIO) today announced the initial list of presenting companies for the...
Aug 21 2014
Washington, D.C. (August 21, 2014) – The Biotechnology Industry Organization (BIO) is pleased to announce that Dr. Richard Raymond, former...
Aug 6 2014
Washington, D.C. (August 6, 2014) – The Biotechnology Industry Organization (BIO) today announces a first-of-its-kind survey tool on FDA/Sponsor...
Aug 5 2014
Washington, D.C. (August 5, 2014) – The Biotechnology Industry Organization (BIO) has opened registration  for the 13th Annual BIO Investor Forum...
Aug 1 2014
Washington, D.C. (August 1, 2014) – The Biotechnology Industry Organization (BIO) has officially extended its Call for Papers deadline to August 20,...


Biotechnology News

October 1, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, announced today that it has secured a $31 million term loan...

October 1, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Stemgent Inc. announced today that it has completed the sale of its stem cell reagents and services business to ReproCELL in a cash...

October 1, 2014

ANN ARBOR, Mich.--(BUSINESS WIRE)--Esperion Therapeutics, Inc. (NASDAQ: ESPR), an emerging pharmaceutical company focused on developing and commercializing first-in-class...

October 1, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ: AFFX) today announced that it will report operating results for the third quarter of 2014 after market...

October 1, 2014

WILLOW GROVE, Pa.--(BUSINESS WIRE)--New Article highlights a more Effective Method for Analyzing Sexual Assault Evidence